A meta-analysis published in The Lancet last August found a one-third increase in the relative risk of major vascular events from diclofenac or coxibs, while high-dose ibuprofen increased the risk of major coronary events.

The EMA said there was no suggestion of a similar cardiovascular risk from lower-dose ibuprofen most commonly used by patients.